HIGHLIGHTS: Emma Walmsley - CEO of GSK
In Good Company with Nicolai Tangen
Advancements and Challenges in the Pharmaceutical Landscape
This chapter explores the pharmaceutical industry's hurdles and prospects, with a focus on unmet medical needs and advancements in science. It discusses the impact of neurodegenerative diseases and emerging obesity treatments, while highlighting the crucial balance between drug pricing and accessibility.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
